179 related articles for article (PubMed ID: 25911963)
1. Difficulties in hematopoietic progenitor cell collection from a patient with TEMPI syndrome and severe iatrogenic iron deficiency.
Belizaire R; Sykes DB; Chen YB; Spitzer TR; Makar RS
Transfusion; 2015 Sep; 55(9):2142-8. PubMed ID: 25911963
[TBL] [Abstract][Full Text] [Related]
2. Harvesting autologous stem cells from a patient with red blood cell abnormalities of β-thalassemia intermedia.
Sanford K; Roseff SD; Anderson J; Chung HM; McPherson RA
Transfusion; 2014 Jul; 54(7):1881-6. PubMed ID: 24527966
[TBL] [Abstract][Full Text] [Related]
3. Mobilization characteristics and strategies to improve hematopoietic progenitor cell mobilization and collection in patients with chronic granulomatous disease and severe combined immunodeficiency.
Panch SR; Yau YY; Kang EM; De Ravin SS; Malech HL; Leitman SF
Transfusion; 2015 Feb; 55(2):265-74. PubMed ID: 25143186
[TBL] [Abstract][Full Text] [Related]
4. The TEMPI syndrome.
Sykes DB; O'Connell C; Schroyens W
Blood; 2020 Apr; 135(15):1199-1203. PubMed ID: 32108223
[TBL] [Abstract][Full Text] [Related]
5. Case report: a 37-year-old male with telangiectasias, polycythemia vera, perinephric fluid collections, and intrapulmonary shunting.
Khan J; Sykes DB
BMC Hematol; 2014; 14(1):11. PubMed ID: 25143825
[TBL] [Abstract][Full Text] [Related]
6. Optia® continuous mononuclear collection (CMNC) system is a safe and efficient system for hematopoietic progenitor cells-apheresis (HPC-a) collection and yields a lower product hematocrit (HCT%) than the COBE® spectra system: A retrospective study.
Pandey S; Cottler-Fox M
J Clin Apher; 2018 Aug; 33(4):505-513. PubMed ID: 29603795
[TBL] [Abstract][Full Text] [Related]
7. Process and procedural adjustments to improve CD34+ collection efficiency of hematopoietic progenitor cell collections in sickle cell disease.
Avecilla ST; Boulad F; Yazdanbakhsh K; Sadelain M; Shi PA
Transfusion; 2021 Sep; 61(9):2775-2781. PubMed ID: 34160085
[TBL] [Abstract][Full Text] [Related]
8. Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program.
Worel N; Rosskopf K; Neumeister P; Kasparu H; Nachbaur D; Russ G; Namberger K; Witt V; Schloegl E; Zojer N; Linkesch W; Kalhs P; Greinix HT
Transfusion; 2011 May; 51(5):968-75. PubMed ID: 20880037
[TBL] [Abstract][Full Text] [Related]
9. Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.
Pusic I; Jiang SY; Landua S; Uy GL; Rettig MP; Cashen AF; Westervelt P; Vij R; Abboud CN; Stockerl-Goldstein KE; Sempek DS; Smith AL; DiPersio JF
Biol Blood Marrow Transplant; 2008 Sep; 14(9):1045-1056. PubMed ID: 18721768
[TBL] [Abstract][Full Text] [Related]
10. An updated single center experience with plerixafor and granulocyte colony-stimulating factor for stem cell mobilization in light chain amyloidosis.
Badar T; Dhakal B; Szabo A; Padmanabhan A; Johnson BD; Heidtke S; Esselmann J; Chhabra S; Hamadani M; Hari P; D'Souza A
J Clin Apher; 2019 Dec; 34(6):686-691. PubMed ID: 31566813
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic progenitor cell collection and neoplastic cell contamination in breast cancer patients receiving chemotherapy plus granulocyte-colony stimulating factor (G-CSF) or G-CSF alone for mobilization.
Bertolini F; Lanza A; Peccatori F; Zibera C; Gibelli N; Perotti C; Da Prada GA; Torretta L; Cocorocchio E; Martinelli G; Robustelli della Cuna G
Ann Oncol; 1998 Aug; 9(8):913-6. PubMed ID: 9789616
[TBL] [Abstract][Full Text] [Related]
12. A novel hematopoietic progenitor cell mobilization and collection algorithm based on preemptive CD34 enumeration.
Storch E; Mark T; Avecilla S; Pagan C; Rhodes J; Shore T; van Besien K; Cushing M
Transfusion; 2015 Aug; 55(8):2010-6. PubMed ID: 25808119
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin lymphoma.
Cashen A; Lopez S; Gao F; Calandra G; MacFarland R; Badel K; DiPersio J
Biol Blood Marrow Transplant; 2008 Nov; 14(11):1253-61. PubMed ID: 18940680
[TBL] [Abstract][Full Text] [Related]
14. Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial.
Nademanee AP; DiPersio JF; Maziarz RT; Stadtmauer EA; Micallef IN; Stiff PJ; Hsu FJ; Bridger G; Bolwell BJ
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1564-72. PubMed ID: 22683613
[TBL] [Abstract][Full Text] [Related]
15. Use of laboratory tests to guide initiation of autologous hematopoietic progenitor cell collection by apheresis: results from the multicenter hematopoietic progenitor cell collection by Apheresis Laboratory Trigger Survey.
Makar RS; Padmanabhan A; Kim HC; Anderson C; Sugrue MW; Linenberger M
Transfus Med Rev; 2014 Oct; 28(4):198-204. PubMed ID: 25311468
[TBL] [Abstract][Full Text] [Related]
16. The use of plerixafor in hematopoietic progenitor cell collection in pediatric patients: a single center experience.
Pham HP; Patel N; Semedei-Pomales M; Bhatia M; Schwartz J
Cytotherapy; 2012 Apr; 14(4):467-72. PubMed ID: 22339604
[TBL] [Abstract][Full Text] [Related]
17. TEMPI Syndrome: Erythrocytosis in Plasma Cell Dyscrasia.
Zhang X; Fang M
Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):724-730. PubMed ID: 30100329
[TBL] [Abstract][Full Text] [Related]
18. Plerixafor and abbreviated-course granulocyte colony-stimulating factor for mobilizing hematopoietic progenitor cells in light chain amyloidosis.
Dhakal B; Strouse C; D'Souza A; Arce-Lara C; Esselman J; Eastwood D; Pasquini M; Saber W; Drobyski W; Rizzo JD; Hari PN; Hamadani M
Biol Blood Marrow Transplant; 2014 Dec; 20(12):1926-31. PubMed ID: 25111581
[TBL] [Abstract][Full Text] [Related]
19. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
20. Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation.
Sautois B; Baudoux E; Salmon JP; Michaux S; Schaaf-Lafontaine N; Pereira M; Paulus JM; Fillet G; Beguin Y
Haematologica; 2001 Nov; 86(11):1209-18. PubMed ID: 11694408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
